Ocular Therapeutix, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Ocular Therapeutix, Inc. on June 2, 2016. The filing details the outcomes of shareholder votes regarding director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters.
Material Changes
No material financial changes are reported in this document. The primary events are the election of Class II directors and the ratification of the accounting firm.
Management Commentary and Governance Results
- Director Elections: Stockholders elected Jaswinder Chadha and Richard L. Lindstrom, M.D. as Class II directors to serve until the 2019 Annual Meeting.
- Auditor Ratification: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the current fiscal year.
Vote Results Table
| Item | Votes For | Votes Against/Withheld | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Election of Jaswinder Chadha | 18,815,688 | 488,339 (Withheld) | N/A | 2,715,777 |
| Election of Richard L. Lindstrom, M.D. | 19,253,668 | 50,359 (Withheld) | N/A | 2,715,777 |
| Ratification of PricewaterhouseCoopers LLP | 22,008,098 | 7,954 (Against) | 3,752 | 0 |
Key Facts for Investor Verification
- Verify the tenure of the newly elected Class II directors (Jaswinder Chadha and Richard L. Lindstrom, M.D.) extending to 2019.
- Confirm the appointment of PricewaterhouseCoopers LLP as the independent auditor for the fiscal year.
- Note the significant number of broker non-votes (2,715,777) recorded for the director elections.